Within the the tumor’s microenvironment, the modulation of γδT cells enhances the antitumor immune response by increasing IFN-γ producing γδT cells (gdTILs) and decreasing IL-17 producing γδT cells, thereby altering immune cell composition and function (Daillère et al., 2016). The gene discussed is IL17A; the disease is neoplasm.